Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter IntfiledCriticalBaxter Int
Priority claimed from PCT/US1995/006784external-prioritypatent/WO1996001118A1/en
Publication of MX9600734ApublicationCriticalpatent/MX9600734A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
A peritoneal dialysis solution that is biochemically balanced to correct metabolic acidosis associated with chronic renal failure in a more physiological manner. The peritoneal dialysis solution has a physiological pH, e.g., pH of 7.0 to 7.4, and contains bicarbonate at a concentration that is found in normal blood. Additionally, the solution contains carbon dioxide at a partial pressure that is similar to partial pressure of carbon dioxide found in normal blood. The peritoneal dialysis solution also contains a weak acid with a pKa of less than 5.0.